Citigroup Upgrades Omega Healthcare Invts to Buy, Raises Price Target to $35
Portfolio Pulse from Benzinga Newsdesk
Citigroup analyst Nicholas Joseph upgraded Omega Healthcare Invts (NYSE:OHI) from Neutral to Buy and increased the price target from $32 to $35.

March 22, 2024 | 9:04 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Citigroup upgraded Omega Healthcare Invts to Buy from Neutral and raised the price target to $35 from $32.
Upgrades by major financial institutions like Citigroup generally lead to positive short-term price movements as they reflect a positive change in the stock's outlook. The increase in price target further supports the expectation of upward movement.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100